(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one
|
|
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one Eigenschaften
- Siedepunkt:
- 706.8±60.0 °C(Predicted)
- Dichte
- 1.264
- storage temp.
- 2-8°C
- Aggregatzustand
- Solid
- pka
- -0.48±0.60(Predicted)
Sicherheit
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one Chemische Eigenschaften,Einsatz,Produktion Methoden
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 172)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Heading (Nanjing)Pharmtechnologies Co., Ltd. | +86-25-58467899-832 +86-13382406280 |
liucheng@headingpharm.com | China | 46 | 58 |
Shanghai Daken Advanced Materials Co.,Ltd | +86-371-66670886 |
info@dakenam.com | China | 18940 | 58 |
Beijing Cooperate Pharmaceutical Co.,Ltd | 010-60279497 |
sales01@cooperate-pharm.com | CHINA | 1803 | 55 |
Shanghai Yingrui Biopharma Co., Ltd. | +86-21-33585366 - 03@ |
sales03@shyrchem.com | CHINA | 738 | 60 |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 32965 | 60 |
career henan chemical co | +86-0371-86658258 +8613203830695 |
sales@coreychem.com | China | 29879 | 58 |
Jinan Shengqi pharmaceutical Co,Ltd | 86+18663751872 |
christine@shengqipharm.com | CHINA | 491 | 58 |
Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 |
sales@chemdad.com | China | 39894 | 58 |
Alchem Pharmtech,Inc. | 8485655694 |
sales@alchempharmtech.com | United States | 63687 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49374 | 58 |
190595-65-4()Verwandte Suche:
- (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one
- E6:synthesis of trans-1-(4-fluorophenyl)-3-[3-oxo-3-(4-fluorophenyl)propyl
- 2-Azetidinone, 1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-[4-(phenylMethoxy)phenyl]-, (3R,4S)-
- 3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopr
- ETMB-06
- EzetiMibe interdiate
- (3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-o
- EZ-ETK
- -3-(3-(4-fluorophenyl)
- -3-oxopropyl)
- -4-(4-(Benzyloxy)
- ZTB-7
- 1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-one
- (3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-
- Ezetimibe Impurity 17
- (3R,4S)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-(4-phenylmethoxyphenyl)azetidin-2-one
- (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one190595-65-4
- (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenChemicalbookyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one
- (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-f...
- Benzaldehyde,4-methoxy-8-(phenylmethoxy)-
- Acetylchloride,2-[5-(trifluoromethyl)phenoxy]-
- Ezetimibe Impuriry 17
- (3R,4S)-4-[4- (benzyloxy) phenyl ]-1-(4- fluorophenyl) -3-[3-(4- fluorophenyl) -3- oxopropyl] azetidine -2- one
- (3R, 4S) -4- [4- (benzyloxy) phenyl] -1- (4-fluorophenyl) -3- [3- (4-fluorophenyl) -3-oxopropyl] azacyclobutane-2-one
- cholesterol-absorption inhibitor Intermediate 2
- Cholesterol absorption inhibitor 1
- Ezetimibe intermediate 1
- 190595-65-4
- C31H25F2NO3
- Ezetimibe intermediates